Dublin, March 09, 2017 -- Research and Markets has announced the addition of the "Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies" report to their offering.
The global market for spinal and neurostimulation intervention products is expected to reach $15.8 billion by 2021 from $12.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.5% from 2016 through 2021.
This report provides:
- An overview of the global markets for surgical, replacement, and neurostimulation technologies as they relate to spinal intervention.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of several types of surgical procedure currently available for the treatment of spinal diseases and injury, including spinal fusion, disc replacement, facet replacement and kyphoplasty, all of which use different products and technologies, and have different advantages and drawbacks.
- Analyses of the market in terms of key product and technology areas, major manufacturers and factors influencing market growth and demand.
- Key corporate activities, including such a mergers & acquisitions, strategic alliances and research & development.
- Profiles of major players in the industry.
The report provides an analysis of the markets for spinal and neurostimulation products, including trends and sales to 2021. It analyzes the market in terms of key product and technology areas, major manufacturers and factors influencing market growth.
Manufacturers of neurostimulation and spinal technologies are discussed and analyzed based on product types, market share and key corporate activities, including a mergers and acquisitions, strategic alliances, and research and development. In addition to neurostimulation products used for the treatment of spinal conditions, the report looks at the wider neurostimulation industry in order to provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in this field.
The report also includes an in-depth analysis of new products and technologies in development, as well as the development of new products that can address a growing number of therapeutic indications.
Excluded from the scope of the report are spinal soft goods, bracing products and externally worn neurostimulation devices.
Key Topics Covered:
1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope Of Report
- Intended Audience
- Information Sources
2: Summary - Complimentary
3: Market Overview
- Applications For Spinal Surgeries
- Applications For Neurostimulation Technologies
4: Current Market Environment
- Major Markets By Product Type
- Major Companies And Market Share
- Major Markets By Region
- Market Trends And Growth Drivers
5: Spinal Implant Products And Technologies
- Spinal Fusion
- Minimally Invasive Spinal Fusion
- Total Disc Replacement
- Dynamic Stabilization
- Biologics
- Fracture Repair
6: Neurostimulation Products And Technologies
- Technological Developments
- Spinal Cord Stimulation Products
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Gastric Stimulation
- Other Forms Of Neurostimulation
7: Product And Technology Pipeline
- Spinal Product Pipeline Devices
- Neurostimulation Product Pipeline
8: Industry Developments
- Mergers And Acquisitions
- Strategic Alliances
9: Company Profiles
- Spinal Product Manufacturers
- Neurostimulation Product Manufacturers
Companies Mentioned
- Alphatec Holdings
- B. Braun/Aesculap
- Boston Scientific
- CVRX
- Depuy Synthes
- Globus Medical
- K2M
- Livanova
- Medtronic
- Medtronic
- Neuropace
- NEVRO
- Nuvasive
- Orthofix International
- St. Jude Medical
- Stryker
- Zimmer Biomet
For more information about this report visit http://www.researchandmarkets.com/research/9vp222/spinal
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Orthopedic Devices, Neurology Devices


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



